PubMed ID:
25714579
Public Release Type:
Journal
Publication Year: 2015
Affiliation: *Massachusetts General Hospital, Harvard Medical School, Boston, MA †Indiana University School of Medicine, Indianapolis, IN ‡Emory University School of Medicine, Atlanta, GA §Cincinnati Children's Hospital, Cincinnati, OH ||Johns Hopkins Bloomberg School of Public Health, Baltimore, MD ¶Columbia University, New York, NY.
DOI:
https://doi.org/10.1097/MPG.0000000000000584
Authors:
Hoofnagle J,
Vuppalanchi R,
Vuppalanchi R,
Kleiner DE,
Chalasani N,
Chalasani N,
Abdelmalek M,
Abrams SH,
Arceo D,
Bambha K,
Barlow S,
Bass NM,
Behling C,
Belt P,
Bhimalli P,
Boyett S,
Brancati F,
Bringman D,
Brunt EM,
Bryan D,
Byam E,
Clark J,
Clark L,
Coffey M,
Colvin R,
Contos MJ,
Corey KE,
Cummings OW,
Cummings OW,
Dasarathy S,
Derdoy J,
Diehl AM,
Donithan M,
Doo E,
Durelle J,
Espinosa D,
Fairly LA,
Feldstein A,
Ferrell LD,
Filipowski D,
Fuchs M,
Gottfried M,
Green M,
Guy C,
Hawkins C,
Hoffmann J,
Hollick R,
Huang TT,
Isaacson M,
Jones A,
Killenberg P,
Kim W,
King D,
Klipsch A,
Kohli R,
Kowdley KV,
Kwan S,
Lavine JE,
Lavine JE,
Lee L,
Liu YC,
Luketic VA,
Lydecker A,
Mann P,
McCullough A,
Mendoza S,
Merriman R,
Miriel L,
Mohan P,
Molleston JP,
Molleston JP,
Mooney J,
Murray KF,
Nair K,
Nelson J,
Neuschwander-Tetri BA,
Nonalcoholic Steatohepatitis Clinical Research Network,
Pabst M,
Pan YP,
Parman Z,
Patton H,
Pfeifer K,
Piercy D,
Ragozzino L,
Robuck PR,
Rosenthal M,
Rosenthal P,
Sandhu B,
Sanyal AJ,
Sargeant C,
Sargent R,
Saunders C,
Scheimann AO,
Schwimmer JB,
Siegner J,
Sirlin C,
Smith M,
Stager M,
Steel T,
Stein T,
Sternberg A,
Stewart S,
Subbarao G,
Thompson J,
Tonascia J,
Torbenson M,
Unalp-Arida A,
Ünalp-Arida A,
Van Natta M,
Vos M,
White M,
Wilson L,
Wilson L,
Yates K,
Yeh M,
Young M
Studies:
Nonalcoholic Steatohepatitis Clinical Research Network
Nonalcoholic fatty liver disease (NAFLD), the most common cause of liver disease among US children, may be associated with cardiovascular disease (CVD) risk. The present study sought to determine the prevalence of dyslipidemia in children with NAFLD and assess dyslipidemia by liver histology and histologic changes.